Literature DB >> 12398020

Myeloma kidney: pathogenesis and treatment.

N Basić-Jukić1, P Kes, B Labar.   

Abstract

Renal failure frequently complicates the course of multiple myeloma. Factors that determine the development of myeloma kidney include a high rate of light chain excretion, biochemical characteristics of light chain, and concurrent volume depletion. There are two main pathogenetic mechanisms; i.e. direct tubular toxicity and intratubular cast formation. Therapeutic measures include chemotherapy, bone marrow or peripheral blood stem cell transplantation, hyperhydration, plasmapheresis, dialysis, solving of hypercalcemia, treatment of anemia with erythropoietin, and avoidance of nephrotoxic drugs and radiocontrast agents. Experimental approach includes administration of colchicines and alkalinization of the urine.

Entities:  

Mesh:

Year:  2001        PMID: 12398020

Source DB:  PubMed          Journal:  Acta Med Croatica        ISSN: 1330-0164


  2 in total

1.  Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules.

Authors:  Jonathan E Phipps; Daniel P Kestler; James S Foster; Stephen J Kennel; Robert Donnell; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Exp Hematol       Date:  2010-07-14       Impact factor: 3.084

2.  State-of-the-Art Management of Complications of Myeloma and Its Treatment.

Authors:  Monique A Hartley-Brown; Daniel M Sullivan; Rachid Baz
Journal:  Adv Hematol       Date:  2010-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.